Closer to an ‘Ideal Inhaler’ with the Easyhaler®
- 169 Downloads
The characteristics of an ideal inhaler are based around the design and formulation of the device, patient use and the clinical effect, together with concordance and patient preference. To ensure consistent drug delivery to the lungs, with regular adherence to the prescribed dosage regimen, it is essential that all these characteristics simultaneously interact to provide smooth and sustained therapeutic control affected only by the clinical status of the patient. The literature highlights that dose emission from an Easyhaler® is fairly consistent irrespective of the inhalation technique used by patients of all age groups. Clinical studies have shown equivalence of this device to those frequently prescribed and that it is preferred by many patients. Although further research is required into the development of inhalation devices, the literature describing the Easyhaler® dry powder inhaler indicates how an inhaler can closely meet the criteria for an ideal inhaler.
KeywordsSalbutamol Budesonide Terbutaline Formoterol Lung Deposition
Prof. Chrystyn has been a consultant to and received grants to attend conferences and educational meetings from numerous companies in the Pharmaceutical Industry that market inhaled products including Ranbaxy (UK) Ltd. Prof. Chrystyn’s research group has also received funds from many of these pharmaceutical companies to carry out research. Prof. Chrystyn has no personal shares with any pharmaceutical company. He was assisted in writing this paper by Joseph Delahunty of Sante Communications [on behalf of Ranbaxy (UK) Ltd].
- 7.United Nations Environmental Program (UNEP). Montreal Protocol on substances that deplete the Ozone Layer. Technology and Assessment Panel, Volumes I and II. Report Volumes I and II. The Netherlands: UNEP, 1997Google Scholar
- 11.Vidgren P, Silvasti M, Poukkula A, et al. Easyhaler powder inhaler: a new alternative in the anti-inflammatory treatment of asthma. Acta Ther 1994; 20: 117–31Google Scholar
- 22.Chrystyn H, Corrado OJ, Brownlee K, et al. Inhalation rates of asthmatic children (CHILD) and adults and of chronic obstructive pulmonary disease (COPD) patients through inhalers. Am J Respir Crit Care Med 2002; 165: A190Google Scholar
- 23.Tarsin W, Hawksworth GM, Haslam GM, et al. Inter- and intravariability of inhalation rates when patients use their dry powder inhalers (DPI) [Abstract]. Thorax 2001; 56Suppl. 3: 60Google Scholar
- 24.Tarsin WY, Assi KA, Pearson SB, et al. Ex-vivo emitted dose characterisation for combination formulations in dry powder inhalers (DPI) [Abstract]. Eur Respir J 2003; 22Suppl. 45: 472sGoogle Scholar
- 31.Vidgren M, Silvasti M, Korhonen P, et al. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol. Drug Res 1995; 45: 44–7Google Scholar
- 38.Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994; 149: 69–76Google Scholar
- 40.Ahonen A, Leinonen M, Ranki-Pesonen M. Patient satisfaction with Easyhaler® compared with other inhalation systems in the treatment of asthma: a meta-analysis. Curr Ther Res Clin Exp 2000; 61: 61–73Google Scholar